251 related articles for article (PubMed ID: 22328927)
1. The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.
Oswald E; Sesarman A; Franzke CW; Wölfle U; Bruckner-Tuderman L; Jakob T; Martin SF; Sitaru C
PLoS One; 2012; 7(2):e31066. PubMed ID: 22328927
[TBL] [Abstract][Full Text] [Related]
2. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
4. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.
Yamamoto K; Inoue N; Masuda R; Fujimori A; Saito T; Imajoh-Ohmi S; Shinkai H; Sakiyama H
J Invest Dermatol; 2002 Mar; 118(3):485-92. PubMed ID: 11874488
[TBL] [Abstract][Full Text] [Related]
5. Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.
Nishie W
Methods Mol Biol; 2013; 961():363-9. PubMed ID: 23325657
[TBL] [Abstract][Full Text] [Related]
6. The role of complement in experimental bullous pemphigoid.
Liu Z; Giudice GJ; Swartz SJ; Fairley JA; Till GO; Troy JL; Diaz LA
J Clin Invest; 1995 Apr; 95(4):1539-44. PubMed ID: 7706459
[TBL] [Abstract][Full Text] [Related]
7. Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice.
Chiriac MT; Licarete E; Sas AG; Rados AM; Lupan I; Chiriac AM; Speth H; Pop-Vancia V; Domsa I; Sesarman A; Popescu O; Sitaru C
Orphanet J Rare Dis; 2013 Jan; 8():17. PubMed ID: 23360583
[TBL] [Abstract][Full Text] [Related]
8. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
Liu Z; Diaz LA; Troy JL; Taylor AF; Emery DJ; Fairley JA; Giudice GJ
J Clin Invest; 1993 Nov; 92(5):2480-8. PubMed ID: 7693763
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of bullous pemphigoid.
Kasperkiewicz M; Zillikens D
Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):67-77. PubMed ID: 18094948
[TBL] [Abstract][Full Text] [Related]
11. Immunopathology of bullous pemphigoid, an autoimmune and inflammatory skin blistering disease.
Liu Z
Keio J Med; 2003 Jun; 52(2):128-33. PubMed ID: 12862365
[TBL] [Abstract][Full Text] [Related]
12. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.
Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E
Front Immunol; 2018; 9():488. PubMed ID: 29599777
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.
Pigors M; Patzelt S; Reichhelm N; Dworschak J; Khil'chenko S; Emtenani S; Bieber K; Hofrichter M; Kamaguchi M; Goletz S; Köhl G; Köhl J; Komorowski L; Probst C; Vanderheyden K; Balbino B; Ludwig RJ; Verheesen P; Schmidt E
J Pathol; 2024 Feb; 262(2):161-174. PubMed ID: 37929639
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
15. Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid.
Schulze FS; Beckmann T; Nimmerjahn F; Ishiko A; Collin M; Köhl J; Goletz S; Zillikens D; Ludwig R; Schmidt E
Am J Pathol; 2014 Aug; 184(8):2185-96. PubMed ID: 25043618
[TBL] [Abstract][Full Text] [Related]
16. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.
Liu Z; Shipley JM; Vu TH; Zhou X; Diaz LA; Werb Z; Senior RM
J Exp Med; 1998 Aug; 188(3):475-82. PubMed ID: 9687525
[TBL] [Abstract][Full Text] [Related]
17. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
Leighty L; Li N; Diaz LA; Liu Z
Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
[TBL] [Abstract][Full Text] [Related]
18. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.
Iwata H; Kitajima Y
Exp Dermatol; 2013 Jun; 22(6):381-5. PubMed ID: 23651418
[TBL] [Abstract][Full Text] [Related]
20. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
